

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 6.58791083 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.51909616 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.51036205 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.83576518 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.77797121 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.77797121 |
| 7 | regulation of B cell differentiation (GO:0045577) | 5.22819993 |
| 8 | positive regulation of B cell differentiation (GO:0045579) | 5.15084959 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.97362389 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.85501037 |
| 11 | detection of bacterium (GO:0016045) | 4.64820658 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.60922327 |
| 13 | detection of other organism (GO:0098543) | 4.57768968 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.48535122 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.34076805 |
| 16 | cellular response to zinc ion (GO:0071294) | 4.32183790 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.23556089 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.23556089 |
| 19 | response to interleukin-15 (GO:0070672) | 4.06420636 |
| 20 | negative regulation of phagocytosis (GO:0050765) | 4.02084551 |
| 21 | leukocyte aggregation (GO:0070486) | 3.96127733 |
| 22 | cellular response to interleukin-15 (GO:0071350) | 3.95796741 |
| 23 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.91454970 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.90552554 |
| 25 | immunoglobulin mediated immune response (GO:0016064) | 3.90229599 |
| 26 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.85835611 |
| 27 | response to peptidoglycan (GO:0032494) | 3.85640710 |
| 28 | mature B cell differentiation (GO:0002335) | 3.85370589 |
| 29 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.83954345 |
| 30 | negative thymic T cell selection (GO:0045060) | 3.82653012 |
| 31 | B cell proliferation (GO:0042100) | 3.81353075 |
| 32 | negative regulation of interleukin-12 production (GO:0032695) | 3.74359618 |
| 33 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.71020415 |
| 34 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.70274270 |
| 35 | negative T cell selection (GO:0043383) | 3.66032129 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.58500468 |
| 37 | thymic T cell selection (GO:0045061) | 3.54669266 |
| 38 | negative regulation of T cell mediated immunity (GO:0002710) | 3.54534958 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.53860212 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52899407 |
| 41 | detection of external biotic stimulus (GO:0098581) | 3.52615110 |
| 42 | T cell migration (GO:0072678) | 3.51184473 |
| 43 | tolerance induction (GO:0002507) | 3.50297760 |
| 44 | regulation of mast cell degranulation (GO:0043304) | 3.48764888 |
| 45 | T cell homeostasis (GO:0043029) | 3.46405741 |
| 46 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.45028926 |
| 47 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.45028926 |
| 48 | respiratory burst (GO:0045730) | 3.39615666 |
| 49 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.38544981 |
| 50 | lymph node development (GO:0048535) | 3.37972255 |
| 51 | lymphocyte homeostasis (GO:0002260) | 3.36637011 |
| 52 | T cell selection (GO:0045058) | 3.35816017 |
| 53 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32257724 |
| 54 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.30684998 |
| 55 | positive T cell selection (GO:0043368) | 3.30153326 |
| 56 | regulation of T cell tolerance induction (GO:0002664) | 3.28021595 |
| 57 | negative regulation of B cell proliferation (GO:0030889) | 3.27718464 |
| 58 | NIK/NF-kappaB signaling (GO:0038061) | 3.25977946 |
| 59 | regulation of B cell proliferation (GO:0030888) | 3.25828486 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.25235321 |
| 61 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.25164884 |
| 62 | response to host immune response (GO:0052572) | 3.25164884 |
| 63 | germinal center formation (GO:0002467) | 3.25152787 |
| 64 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.22330217 |
| 65 | neutrophil activation involved in immune response (GO:0002283) | 3.22197404 |
| 66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.22018733 |
| 67 | mature B cell differentiation involved in immune response (GO:0002313) | 3.21514005 |
| 68 | ribosomal small subunit assembly (GO:0000028) | 3.21450241 |
| 69 | mast cell activation (GO:0045576) | 3.20913243 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.19808676 |
| 71 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19756546 |
| 72 | B cell homeostasis (GO:0001782) | 3.18703771 |
| 73 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.17653502 |
| 74 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.16973539 |
| 75 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.13911167 |
| 76 | positive regulation of mast cell activation (GO:0033005) | 3.13788283 |
| 77 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.13626750 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.12963118 |
| 79 | * defense response to protozoan (GO:0042832) | 3.12617818 |
| 80 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.11679157 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 3.11036811 |
| 82 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09858563 |
| 83 | regulation of tolerance induction (GO:0002643) | 3.08924837 |
| 84 | detection of biotic stimulus (GO:0009595) | 3.08411864 |
| 85 | B cell mediated immunity (GO:0019724) | 3.06929912 |
| 86 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.06555710 |
| 87 | regulation of mast cell activation (GO:0033003) | 3.05694069 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.05576055 |
| 89 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.04958357 |
| 90 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.04958357 |
| 91 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.04685216 |
| 92 | neutrophil activation (GO:0042119) | 3.03159593 |
| 93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.02229551 |
| 94 | B cell activation (GO:0042113) | 3.02029451 |
| 95 | T cell costimulation (GO:0031295) | 3.01745736 |
| 96 | positive regulation of B cell activation (GO:0050871) | 3.01216434 |
| 97 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.00480487 |
| 98 | microglial cell activation (GO:0001774) | 3.00263311 |
| 99 | leukocyte homeostasis (GO:0001776) | 2.99513125 |
| 100 | regulation of interferon-alpha production (GO:0032647) | 2.98713056 |
| 101 | leukocyte degranulation (GO:0043299) | 2.98338428 |
| 102 | regulation of B cell apoptotic process (GO:0002902) | 2.98327780 |
| 103 | lymphocyte costimulation (GO:0031294) | 2.96302561 |
| 104 | response to host (GO:0075136) | 2.95371843 |
| 105 | response to host defenses (GO:0052200) | 2.95371843 |
| 106 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95371843 |
| 107 | positive regulation of type 2 immune response (GO:0002830) | 2.93736751 |
| 108 | negative regulation of innate immune response (GO:0045824) | 2.93335664 |
| 109 | cellular extravasation (GO:0045123) | 2.92089225 |
| 110 | positive regulation of B cell proliferation (GO:0030890) | 2.90530942 |
| 111 | regulation of B cell activation (GO:0050864) | 2.89548492 |
| 112 | positive regulation of granulocyte differentiation (GO:0030854) | 2.88428150 |
| 113 | mononuclear cell proliferation (GO:0032943) | 2.87188632 |
| 114 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87150364 |
| 115 | modulation by symbiont of host defense response (GO:0052031) | 2.87150364 |
| 116 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87150364 |
| 117 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87150364 |
| 118 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87150364 |
| 119 | modulation by symbiont of host immune response (GO:0052553) | 2.87150364 |
| 120 | myeloid dendritic cell activation (GO:0001773) | 2.86452546 |
| 121 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.86294775 |
| 122 | positive regulation of interleukin-2 production (GO:0032743) | 2.86113268 |
| 123 | macrophage activation involved in immune response (GO:0002281) | 2.85747929 |
| 124 | lymphocyte proliferation (GO:0046651) | 2.84842258 |
| 125 | response to type I interferon (GO:0034340) | 2.84457779 |
| 126 | T cell receptor signaling pathway (GO:0050852) | 2.83004095 |
| 127 | leukocyte cell-cell adhesion (GO:0007159) | 2.78358203 |
| 128 | cellular response to type I interferon (GO:0071357) | 2.78056059 |
| 129 | type I interferon signaling pathway (GO:0060337) | 2.78056059 |
| 130 | viral transcription (GO:0019083) | 2.76635870 |
| 131 | natural killer cell differentiation (GO:0001779) | 2.76568892 |
| 132 | interferon-gamma production (GO:0032609) | 2.75963807 |
| 133 | granulocyte activation (GO:0036230) | 2.75206013 |
| 134 | regulation of antigen processing and presentation (GO:0002577) | 2.74101257 |
| 135 | positive regulation of lamellipodium assembly (GO:0010592) | 2.72467567 |
| 136 | mast cell degranulation (GO:0043303) | 2.69431239 |
| 137 | mast cell activation involved in immune response (GO:0002279) | 2.69431239 |
| 138 | B cell differentiation (GO:0030183) | 2.68120134 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.67564037 |
| 140 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.67072814 |
| 141 | myeloid cell activation involved in immune response (GO:0002275) | 2.66785554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94536771 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.58352752 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.00920444 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.99417602 |
| 5 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.82140347 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.77077097 |
| 7 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.52408726 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52223754 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43408973 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.22932168 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82262111 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.71591109 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61718382 |
| 14 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.59058751 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.52517366 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.49472527 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.44868482 |
| 18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.41347239 |
| 19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.40363997 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38220378 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.35257417 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.34022028 |
| 23 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.33021231 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32504564 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.29144361 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28862173 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27628747 |
| 28 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.25876982 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22906383 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.17095138 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.16421369 |
| 32 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07003753 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03560739 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.00997520 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.94777574 |
| 36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94244567 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.94073192 |
| 38 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.89266146 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86053995 |
| 40 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.85593684 |
| 41 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.84591578 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.84516952 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.82386343 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76660006 |
| 45 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.74120129 |
| 46 | MAF_26560356_Chip-Seq_TH2_Human | 1.69449093 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69083004 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68335051 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66679156 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49170093 |
| 51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.49079963 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48209527 |
| 53 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47424658 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44044411 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.42952257 |
| 56 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42527779 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41378859 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.40714905 |
| 59 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40373443 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.39571313 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38444350 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36108564 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33611504 |
| 64 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.32626549 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30419390 |
| 66 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.29847128 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28421367 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28353255 |
| 69 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26108140 |
| 70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.25406481 |
| 71 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.24724802 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.22930877 |
| 73 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21480684 |
| 74 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.21280406 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21208987 |
| 76 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21206055 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20062332 |
| 78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19231572 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17577282 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.17120938 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16572550 |
| 82 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11851154 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11044033 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09753357 |
| 85 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.06742774 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05315335 |
| 87 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04750137 |
| 88 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.03789097 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03356569 |
| 90 | GATA3_26560356_Chip-Seq_TH2_Human | 1.02211029 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01713652 |
| 92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01513316 |
| 93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99358980 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98488984 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96509733 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95619764 |
| 97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92705966 |
| 98 | * P300_27268052_Chip-Seq_Bcells_Human | 0.89646265 |
| 99 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88341905 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.87359515 |
| 101 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87284604 |
| 102 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86712814 |
| 103 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86635682 |
| 104 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.85976481 |
| 105 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85773697 |
| 106 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85671299 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84554704 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84513081 |
| 109 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84269532 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.83679905 |
| 111 | P68_20966046_ChIP-Seq_HELA_Human | 0.83446578 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83405552 |
| 113 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83073891 |
| 114 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.83053691 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.77264287 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.77254920 |
| 117 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75750219 |
| 118 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75731863 |
| 119 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.75535935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.92692225 |
| 2 | * MP0001800_abnormal_humoral_immune | 4.02148968 |
| 3 | MP0005387_immune_system_phenotype | 3.98819837 |
| 4 | MP0001790_abnormal_immune_system | 3.98819837 |
| 5 | MP0000685_abnormal_immune_system | 3.72859452 |
| 6 | MP0005671_abnormal_response_to | 3.45251184 |
| 7 | * MP0002452_abnormal_antigen_presenting | 3.28484841 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.16319151 |
| 9 | MP0003303_peritoneal_inflammation | 3.02401646 |
| 10 | * MP0002723_abnormal_immune_serum | 2.96995374 |
| 11 | * MP0002420_abnormal_adaptive_immunity | 2.96500018 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.94677993 |
| 13 | * MP0001819_abnormal_immune_cell | 2.90217181 |
| 14 | * MP0002398_abnormal_bone_marrow | 2.82366982 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.70807849 |
| 16 | MP0009785_altered_susceptibility_to | 2.63416709 |
| 17 | * MP0000716_abnormal_immune_system | 2.56425205 |
| 18 | MP0005025_abnormal_response_to | 2.54622648 |
| 19 | MP0003436_decreased_susceptibility_to | 2.53169540 |
| 20 | * MP0000689_abnormal_spleen_morphology | 2.47036001 |
| 21 | MP0002419_abnormal_innate_immunity | 2.38926314 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.24563586 |
| 23 | * MP0002722_abnormal_immune_system | 2.23008797 |
| 24 | MP0002166_altered_tumor_susceptibility | 2.21878299 |
| 25 | * MP0002429_abnormal_blood_cell | 2.15011695 |
| 26 | MP0002405_respiratory_system_inflammati | 2.10704028 |
| 27 | MP0001873_stomach_inflammation | 2.07962885 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.01620720 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.98363713 |
| 30 | MP0004808_abnormal_hematopoietic_stem | 1.94413505 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.92616616 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.84107622 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.81719325 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.78975016 |
| 35 | MP0001853_heart_inflammation | 1.78077011 |
| 36 | MP0004947_skin_inflammation | 1.67432004 |
| 37 | MP0002006_tumorigenesis | 1.65248120 |
| 38 | MP0006082_CNS_inflammation | 1.63763756 |
| 39 | MP0004510_myositis | 1.57819254 |
| 40 | MP0003866_abnormal_defecation | 1.47990375 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.46582150 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.45982871 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.45907263 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.45907263 |
| 45 | MP0002933_joint_inflammation | 1.45220274 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.40966725 |
| 47 | MP0009278_abnormal_bone_marrow | 1.39645959 |
| 48 | MP0008057_abnormal_DNA_replication | 1.31578545 |
| 49 | MP0005310_abnormal_salivary_gland | 1.30457771 |
| 50 | MP0000490_abnormal_crypts_of | 1.29002483 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.26482649 |
| 52 | MP0003724_increased_susceptibility_to | 1.23410732 |
| 53 | MP0008469_abnormal_protein_level | 1.22758784 |
| 54 | MP0004381_abnormal_hair_follicle | 1.20536887 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.18146880 |
| 56 | MP0008260_abnormal_autophagy | 1.18053712 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.15746323 |
| 58 | MP0001533_abnormal_skeleton_physiology | 1.13927985 |
| 59 | MP0010094_abnormal_chromosome_stability | 1.12569805 |
| 60 | MP0003077_abnormal_cell_cycle | 1.10304261 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.09367051 |
| 62 | MP0003191_abnormal_cellular_cholesterol | 1.06562583 |
| 63 | MP0001986_abnormal_taste_sensitivity | 1.01523182 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.00623197 |
| 65 | MP0003693_abnormal_embryo_hatching | 0.96723785 |
| 66 | MP0000015_abnormal_ear_pigmentation | 0.93488551 |
| 67 | MP0005451_abnormal_body_composition | 0.93389768 |
| 68 | MP0000858_altered_metastatic_potential | 0.92498371 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 0.91053291 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 0.87712681 |
| 71 | MP0004883_abnormal_blood_vessel | 0.87521014 |
| 72 | MP0002095_abnormal_skin_pigmentation | 0.85517439 |
| 73 | MP0003075_altered_response_to | 0.84201569 |
| 74 | MP0002009_preneoplasia | 0.81705062 |
| 75 | MP0010307_abnormal_tumor_latency | 0.81099762 |
| 76 | MP0003448_altered_tumor_morphology | 0.80500733 |
| 77 | MP0006054_spinal_hemorrhage | 0.74962642 |
| 78 | MP0003111_abnormal_nucleus_morphology | 0.74219327 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.73589549 |
| 80 | MP0008004_abnormal_stomach_pH | 0.72364347 |
| 81 | MP0009764_decreased_sensitivity_to | 0.69614287 |
| 82 | MP0001663_abnormal_digestive_system | 0.69031989 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.68683886 |
| 84 | MP0000313_abnormal_cell_death | 0.67996500 |
| 85 | MP0005390_skeleton_phenotype | 0.67761095 |
| 86 | MP0008058_abnormal_DNA_repair | 0.66437303 |
| 87 | MP0001851_eye_inflammation | 0.66081219 |
| 88 | MP0003690_abnormal_glial_cell | 0.65033014 |
| 89 | MP0000249_abnormal_blood_vessel | 0.63980544 |
| 90 | MP0005166_decreased_susceptibility_to | 0.62123100 |
| 91 | MP0009763_increased_sensitivity_to | 0.61000790 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.60888696 |
| 93 | MP0002928_abnormal_bile_duct | 0.60014652 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.59923923 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.59862693 |
| 96 | MP0005023_abnormal_wound_healing | 0.59012416 |
| 97 | MP0004957_abnormal_blastocyst_morpholog | 0.58592890 |
| 98 | MP0000350_abnormal_cell_proliferation | 0.57588608 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.57572185 |
| 100 | MP0002998_abnormal_bone_remodeling | 0.57128990 |
| 101 | MP0005381_digestive/alimentary_phenotyp | 0.55980882 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.55900097 |
| 103 | MP0003045_fibrosis | 0.54671704 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.54140153 |
| 105 | MP0005164_abnormal_response_to | 0.53500964 |
| 106 | MP0009840_abnormal_foam_cell | 0.53480105 |
| 107 | MP0002132_abnormal_respiratory_system | 0.53365615 |
| 108 | MP0003795_abnormal_bone_structure | 0.53289386 |
| 109 | MP0003828_pulmonary_edema | 0.53027964 |
| 110 | MP0000343_altered_response_to | 0.52823901 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.51193449 |
| 112 | MP0000371_diluted_coat_color | 0.50278526 |
| 113 | MP0000604_amyloidosis | 0.50157585 |
| 114 | MP0003091_abnormal_cell_migration | 0.49711062 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.49131307 |
| 116 | MP0005621_abnormal_cell_physiology | 0.49118489 |
| 117 | MP0008874_decreased_physiological_sensi | 0.48707552 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.46618989 |
| 119 | MP0000598_abnormal_liver_morphology | 0.44205409 |
| 120 | MP0000609_abnormal_liver_physiology | 0.41313361 |
| 121 | MP0005535_abnormal_body_temperature | 0.40805507 |
| 122 | MP0009642_abnormal_blood_homeostasis | 0.40036181 |
| 123 | MP0005319_abnormal_enzyme/_coenzyme | 0.39619593 |
| 124 | MP0004130_abnormal_muscle_cell | 0.38999771 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.37081878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 7.08658698 |
| 2 | Recurrent bronchitis (HP:0002837) | 5.68071357 |
| 3 | Gastrointestinal stroma tumor (HP:0100723) | 5.28642665 |
| 4 | IgM deficiency (HP:0002850) | 5.24108319 |
| 5 | Cellulitis (HP:0100658) | 5.21910017 |
| 6 | Recurrent viral infections (HP:0004429) | 4.70216239 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.66298232 |
| 8 | Colitis (HP:0002583) | 4.57878378 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 4.52028455 |
| 10 | Recurrent sinusitis (HP:0011108) | 4.51178744 |
| 11 | Meningitis (HP:0001287) | 4.42400528 |
| 12 | Chronic otitis media (HP:0000389) | 4.35308611 |
| 13 | Inflammation of the large intestine (HP:0002037) | 4.34642748 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.31960192 |
| 15 | Verrucae (HP:0200043) | 4.29824700 |
| 16 | Papilloma (HP:0012740) | 4.29824700 |
| 17 | Orchitis (HP:0100796) | 4.24939957 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 4.24088404 |
| 19 | Lymphopenia (HP:0001888) | 4.18897300 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 4.13921817 |
| 21 | Optic neuritis (HP:0100653) | 4.13921817 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 4.12851310 |
| 23 | Recurrent fungal infections (HP:0002841) | 4.05186184 |
| 24 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.03573191 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.76435460 |
| 26 | Recurrent cutaneous fungal infections (HP:0011370) | 3.68110100 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.68110100 |
| 28 | Thyroiditis (HP:0100646) | 3.64099783 |
| 29 | Vasculitis (HP:0002633) | 3.63794359 |
| 30 | Gastrointestinal infarctions (HP:0005244) | 3.62375894 |
| 31 | Chronic sinusitis (HP:0011109) | 3.61857314 |
| 32 | B lymphocytopenia (HP:0010976) | 3.61852924 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.61852924 |
| 34 | Emphysema (HP:0002097) | 3.53721385 |
| 35 | Abnormality of T cells (HP:0002843) | 3.39119717 |
| 36 | T lymphocytopenia (HP:0005403) | 3.38946916 |
| 37 | Mediastinal lymphadenopathy (HP:0100721) | 3.36635379 |
| 38 | Recurrent skin infections (HP:0001581) | 3.34826792 |
| 39 | Osteomyelitis (HP:0002754) | 3.32922830 |
| 40 | Abnormality of T cell number (HP:0011839) | 3.28388994 |
| 41 | IgA deficiency (HP:0002720) | 3.25314602 |
| 42 | Thrombocytosis (HP:0001894) | 3.22355047 |
| 43 | Urticaria (HP:0001025) | 3.22236873 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 3.21505254 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.20709113 |
| 46 | Bronchitis (HP:0012387) | 3.18535136 |
| 47 | IgG deficiency (HP:0004315) | 3.15114249 |
| 48 | Recurrent pneumonia (HP:0006532) | 3.14489909 |
| 49 | Recurrent lower respiratory tract infections (HP:0002783) | 3.05755789 |
| 50 | Abnormality of the fingertips (HP:0001211) | 3.05645715 |
| 51 | Nasal polyposis (HP:0100582) | 3.05237112 |
| 52 | Restrictive lung disease (HP:0002091) | 3.00554893 |
| 53 | Pustule (HP:0200039) | 2.98217966 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.97190827 |
| 55 | Obstructive lung disease (HP:0006536) | 2.95295109 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95295109 |
| 57 | Myositis (HP:0100614) | 2.94935092 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.94582904 |
| 59 | Sepsis (HP:0100806) | 2.93872236 |
| 60 | Chronic diarrhea (HP:0002028) | 2.89405300 |
| 61 | Hemoptysis (HP:0002105) | 2.84505483 |
| 62 | Recurrent otitis media (HP:0000403) | 2.84288158 |
| 63 | Increased IgM level (HP:0003496) | 2.80204926 |
| 64 | Lymphoma (HP:0002665) | 2.79459504 |
| 65 | Keratoconjunctivitis (HP:0001096) | 2.78441013 |
| 66 | Combined immunodeficiency (HP:0005387) | 2.73408680 |
| 67 | Severe combined immunodeficiency (HP:0004430) | 2.72694644 |
| 68 | Hypochromic anemia (HP:0001931) | 2.72185647 |
| 69 | Hypochromic microcytic anemia (HP:0004840) | 2.67612073 |
| 70 | Abnormality of the nasal mucosa (HP:0000433) | 2.60738296 |
| 71 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55625683 |
| 72 | Pulmonary embolism (HP:0002204) | 2.52878467 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.48546257 |
| 74 | Spontaneous hematomas (HP:0007420) | 2.46876472 |
| 75 | Abnormality of the prostate (HP:0008775) | 2.46713702 |
| 76 | Interstitial pulmonary disease (HP:0006530) | 2.45976536 |
| 77 | Petechiae (HP:0000967) | 2.43685173 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.43495302 |
| 79 | Encephalitis (HP:0002383) | 2.41913607 |
| 80 | Leukopenia (HP:0001882) | 2.40788595 |
| 81 | Episodic fever (HP:0001954) | 2.38549839 |
| 82 | Eosinophilia (HP:0001880) | 2.33924866 |
| 83 | Purpura (HP:0000979) | 2.31735838 |
| 84 | Stomatitis (HP:0010280) | 2.31635677 |
| 85 | Skin ulcer (HP:0200042) | 2.31619810 |
| 86 | Autoimmune hemolytic anemia (HP:0001890) | 2.29429895 |
| 87 | Abnormality of macrophages (HP:0004311) | 2.28940825 |
| 88 | Increased IgE level (HP:0003212) | 2.28843136 |
| 89 | Small epiphyses (HP:0010585) | 2.26872529 |
| 90 | Anorexia (HP:0002039) | 2.26456069 |
| 91 | Abnormality of eosinophils (HP:0001879) | 2.24604505 |
| 92 | Skin rash (HP:0000988) | 2.24503436 |
| 93 | Pulmonary infiltrates (HP:0002113) | 2.23981404 |
| 94 | Leukocytosis (HP:0001974) | 2.20538707 |
| 95 | Granulocytopenia (HP:0001913) | 2.18782562 |
| 96 | Gangrene (HP:0100758) | 2.17459004 |
| 97 | Hypoplasia of the thymus (HP:0000778) | 2.15376667 |
| 98 | Periodontitis (HP:0000704) | 2.10706648 |
| 99 | Microcytic anemia (HP:0001935) | 2.08011602 |
| 100 | Viral hepatitis (HP:0006562) | 2.07341979 |
| 101 | Neutropenia (HP:0001875) | 2.07318336 |
| 102 | Mitral stenosis (HP:0001718) | 2.03850601 |
| 103 | Gingivitis (HP:0000230) | 2.01984504 |
| 104 | Chest pain (HP:0100749) | 2.01973435 |
| 105 | Abnormality of the peritoneum (HP:0002585) | 2.01144111 |
| 106 | Epistaxis (HP:0000421) | 1.99304011 |
| 107 | Papilledema (HP:0001085) | 1.99084806 |
| 108 | Hematochezia (HP:0002573) | 1.97790809 |
| 109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.94941254 |
| 110 | Basal cell carcinoma (HP:0002671) | 1.93041210 |
| 111 | Arthralgia (HP:0002829) | 1.92909938 |
| 112 | Glomerulopathy (HP:0100820) | 1.92830917 |
| 113 | Increased cerebral lipofuscin (HP:0011813) | 1.90301639 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.89617065 |
| 115 | Abnormal platelet function (HP:0011869) | 1.89617065 |
| 116 | Hypertensive crisis (HP:0100735) | 1.89568314 |
| 117 | Reticulocytopenia (HP:0001896) | 1.89428625 |
| 118 | Increased serum ferritin (HP:0003281) | 1.88406449 |
| 119 | Fatigue (HP:0012378) | 1.82201776 |
| 120 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.80211051 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.80202620 |
| 122 | Poikiloderma (HP:0001029) | 1.79991739 |
| 123 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.78089769 |
| 124 | Arterial thrombosis (HP:0004420) | 1.77525818 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.74133815 |
| 126 | Gingival bleeding (HP:0000225) | 1.73921375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.44390452 |
| 2 | MAP3K10 | 3.14318667 |
| 3 | BLK | 3.02154729 |
| 4 | CSF1R | 2.77170328 |
| 5 | GRK6 | 2.77135224 |
| 6 | ERN1 | 2.72533168 |
| 7 | BTK | 2.61047496 |
| 8 | SYK | 2.43894327 |
| 9 | STK10 | 2.33020683 |
| 10 | TYK2 | 2.30143681 |
| 11 | PRPF4B | 2.21442738 |
| 12 | KIT | 2.21431480 |
| 13 | EEF2K | 2.08476408 |
| 14 | ZAP70 | 1.98534083 |
| 15 | RIPK4 | 1.92796130 |
| 16 | MAP3K14 | 1.91812926 |
| 17 | LRRK2 | 1.84809516 |
| 18 | TBK1 | 1.79935630 |
| 19 | IRAK4 | 1.78732264 |
| 20 | SIK2 | 1.78274435 |
| 21 | JAK3 | 1.75411207 |
| 22 | MAP3K13 | 1.74433905 |
| 23 | JAK1 | 1.71074138 |
| 24 | TXK | 1.66896236 |
| 25 | TEC | 1.64743741 |
| 26 | IKBKE | 1.61615684 |
| 27 | ITK | 1.54502714 |
| 28 | LYN | 1.53152726 |
| 29 | HCK | 1.48713735 |
| 30 | CLK1 | 1.43680442 |
| 31 | TGFBR2 | 1.43281986 |
| 32 | LCK | 1.39051720 |
| 33 | FES | 1.36311984 |
| 34 | CSK | 1.35545248 |
| 35 | IKBKB | 1.32299423 |
| 36 | BMPR2 | 1.25932146 |
| 37 | IRAK3 | 1.22055276 |
| 38 | TAOK1 | 1.15474930 |
| 39 | FGR | 1.12077342 |
| 40 | MAP2K3 | 1.11376593 |
| 41 | CDK12 | 1.10550296 |
| 42 | PIM1 | 1.10498023 |
| 43 | MARK3 | 1.09701873 |
| 44 | MAP3K3 | 1.06492610 |
| 45 | SIK3 | 1.03096524 |
| 46 | RPS6KA4 | 0.93025166 |
| 47 | PKN2 | 0.92632864 |
| 48 | FLT3 | 0.91505115 |
| 49 | TRIB3 | 0.90353287 |
| 50 | MAP3K1 | 0.89982449 |
| 51 | NEK2 | 0.88707158 |
| 52 | CDK19 | 0.88490038 |
| 53 | CDK4 | 0.87633755 |
| 54 | TNK2 | 0.86393616 |
| 55 | KDR | 0.82737661 |
| 56 | MST4 | 0.81877823 |
| 57 | MARK2 | 0.79872604 |
| 58 | TESK2 | 0.79415204 |
| 59 | EIF2AK3 | 0.78725621 |
| 60 | FGFR4 | 0.78336351 |
| 61 | MATK | 0.78286995 |
| 62 | FGFR3 | 0.77790514 |
| 63 | NLK | 0.77538491 |
| 64 | TAOK3 | 0.75762751 |
| 65 | CHUK | 0.75420735 |
| 66 | SMG1 | 0.74731453 |
| 67 | PRKCQ | 0.73594873 |
| 68 | PASK | 0.72608926 |
| 69 | CDC42BPA | 0.71011040 |
| 70 | NME2 | 0.70650184 |
| 71 | TAOK2 | 0.66766039 |
| 72 | STK4 | 0.64275584 |
| 73 | IRAK1 | 0.64090193 |
| 74 | SCYL2 | 0.63423065 |
| 75 | PRKCH | 0.61131550 |
| 76 | BRD4 | 0.56325498 |
| 77 | PIK3CG | 0.56054444 |
| 78 | YES1 | 0.56013104 |
| 79 | HIPK2 | 0.54952904 |
| 80 | PDPK1 | 0.53685152 |
| 81 | MAPK12 | 0.53222507 |
| 82 | IRAK2 | 0.51652388 |
| 83 | MAPK4 | 0.51451598 |
| 84 | MAP3K7 | 0.51376326 |
| 85 | JAK2 | 0.50760205 |
| 86 | STK11 | 0.49755925 |
| 87 | KSR2 | 0.49403038 |
| 88 | MAP2K2 | 0.49105777 |
| 89 | RPS6KB2 | 0.48669892 |
| 90 | CAMKK1 | 0.47827463 |
| 91 | ABL1 | 0.47427249 |
| 92 | MAPK11 | 0.47326173 |
| 93 | EPHB1 | 0.47308321 |
| 94 | PDK1 | 0.46875055 |
| 95 | SIK1 | 0.46318510 |
| 96 | ALK | 0.44737441 |
| 97 | GRK1 | 0.43487766 |
| 98 | MAP3K8 | 0.40424376 |
| 99 | DYRK1B | 0.39460664 |
| 100 | RPS6KA6 | 0.39215715 |
| 101 | PRKD2 | 0.38705766 |
| 102 | MAPKAPK2 | 0.38290654 |
| 103 | CDK9 | 0.38129846 |
| 104 | MAPK7 | 0.35817958 |
| 105 | ATR | 0.35631509 |
| 106 | FYN | 0.34667968 |
| 107 | CAMK1D | 0.34551508 |
| 108 | GRK7 | 0.32848307 |
| 109 | PIM2 | 0.32806800 |
| 110 | CDK6 | 0.31686919 |
| 111 | PTK2B | 0.29759003 |
| 112 | PRKCD | 0.29146906 |
| 113 | MELK | 0.29057728 |
| 114 | RPS6KL1 | 0.28892591 |
| 115 | RPS6KC1 | 0.28892591 |
| 116 | CDC7 | 0.28556397 |
| 117 | MAP2K6 | 0.27604666 |
| 118 | NEK9 | 0.25932092 |
| 119 | INSR | 0.25804806 |
| 120 | EGFR | 0.25653140 |
| 121 | PTK6 | 0.25386985 |
| 122 | MAP3K11 | 0.25184636 |
| 123 | TLK1 | 0.25087058 |
| 124 | CAMKK2 | 0.24913001 |
| 125 | TGFBR1 | 0.24492969 |
| 126 | MAPK3 | 0.23002985 |
| 127 | PRKD1 | 0.22454326 |
| 128 | MAP3K5 | 0.21991356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.37809294 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 4.30040007 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.62376993 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47158711 |
| 5 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.45533381 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.40712001 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.35480267 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23337775 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.16733518 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.99668116 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 1.98494973 |
| 12 | Measles_Homo sapiens_hsa05162 | 1.97323620 |
| 13 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.92631571 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.80589699 |
| 15 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.74530773 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.73659552 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67028249 |
| 18 | Mismatch repair_Homo sapiens_hsa03430 | 1.65743958 |
| 19 | Ribosome_Homo sapiens_hsa03010 | 1.56117461 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.55497754 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.55140453 |
| 22 | Other glycan degradation_Homo sapiens_hsa00511 | 1.49833490 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.48499925 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.42179005 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.40006126 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39098237 |
| 27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.38231519 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.37282392 |
| 29 | Shigellosis_Homo sapiens_hsa05131 | 1.32436944 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31784111 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.31660639 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.30310680 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28488313 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27341847 |
| 35 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.22615242 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.22287157 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.21754708 |
| 38 | Allograft rejection_Homo sapiens_hsa05330 | 1.20140642 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.18517242 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.15398780 |
| 41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.15218408 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 1.14729612 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.14013040 |
| 44 | Phagosome_Homo sapiens_hsa04145 | 1.10095278 |
| 45 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09446043 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07709743 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06294947 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.02478994 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.01877596 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 1.01300427 |
| 51 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.01099864 |
| 52 | Homologous recombination_Homo sapiens_hsa03440 | 0.99870015 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.98792908 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.96057805 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95771443 |
| 56 | Asthma_Homo sapiens_hsa05310 | 0.92544221 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91536846 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90611206 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87499955 |
| 60 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86717675 |
| 61 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84130153 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84104327 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83719321 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.80082284 |
| 65 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77938741 |
| 66 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71425328 |
| 67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69646613 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67841059 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 0.67007115 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.64913558 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63280507 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62815573 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62372931 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57900041 |
| 75 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57655997 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57405748 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54452062 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54164390 |
| 79 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53412347 |
| 80 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49223369 |
| 81 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.48528856 |
| 82 | Cell cycle_Homo sapiens_hsa04110 | 0.48292004 |
| 83 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46815665 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45570455 |
| 85 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44755385 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44257509 |
| 87 | RNA degradation_Homo sapiens_hsa03018 | 0.43892461 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.43793496 |
| 89 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.41294220 |
| 90 | Endocytosis_Homo sapiens_hsa04144 | 0.40817604 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40429051 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40073413 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39419543 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38290818 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36805187 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35179604 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34710806 |
| 98 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33517641 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33396360 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33355610 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32260841 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.31234953 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.31038289 |
| 104 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30764000 |
| 105 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30148787 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29942906 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28968201 |
| 108 | RNA transport_Homo sapiens_hsa03013 | 0.28890653 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.28154310 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27574756 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27217135 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.27035377 |
| 113 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.26956804 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26855255 |
| 115 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.26178221 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24043930 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23805087 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.23153523 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23058764 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20791508 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.16791751 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.16296762 |
| 123 | Prostate cancer_Homo sapiens_hsa05215 | 0.15045935 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14933012 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.12552457 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.12195754 |

